CTLA4 and cancer: Two meta-analyses found similar results regarding the rs231775 variant, showing an associated risk for cancer development even through subgroup analysis by type and ethnicity suggesting that CTLA-4 rs231775 is a key variant that could be associated with cancer development [58,59].